Skip to content

Biomarker reserch for prediction to resolve nonalcoholic liver diseases by bariatric surgery

Biomarker reserch for prediction to resolve nonalcoholic liver diseases by bariatric surgery - Biomarker reserch for prediction to resolve nonalcoholic liver diseases by bariatric surgery

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
JPRN
Registry ID
JPRN-UMIN000048265
Enrollment
100
Registered
2022-07-11
Start date
2022-07-11
Completion date
Unknown
Last updated
2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Nonalcoholic fatty liver disease

Interventions

None listed

Sponsors

Keio University, School of Medicine Division of Gastroenterology and Hepatology
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: Patients to have bariatric surgery with BMI>=32.5kg/m2 medicine treatment-refractory morbid obesity.

Exclusion criteria

Exclusion criteria: Patients with a medical history of gastric surgery or uncontrolled mental illness, drug addiction and alcohol use disorder

Design outcomes

Primary

MeasureTime frame
The serum cytokine profiles 12weeks after bariatric surgery

Secondary

MeasureTime frame
The serum cytokine profiles 24 and 48weeks after bariatric surgery

Countries

Japan

Contacts

Public ContactNobuhiro Nakamoto

Keio University, School of Medicine Division of Gastroenterology and Hepatology

nobuhiro@z2.keio.jp+81-3-3353-1211

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026